Pfizer Inc (NYSE: PFE)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 09/22/2023
Closing price: 32.69
Support price level: | N/A |
Resistance price level: | $35.29 |
Relative strength index (14-day RSI) | 14.5 |
Beta | 0.53 |
- PFE is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- With a -25.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- PFE is one of this month's worst performers with a return of -9.6%, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- With RSI < 30, PFE is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$32.69 | $54.48 | 0.0% |
200 day | 50 day | 20 day | 10 day |
$40.43 | $35.54 | $34.56 | $33.72 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
28.1% | 21.9% | 21.9% | 26.0% |
- 6.0% in the next week.
- 14.7% in the next month.
- .% in the next year.
Company news for Pfizer Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks